Name: Latest research reports of Abbott India Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer

26685.0000 340.00 (1.29%)

NSE Nov 08, 2026 15:31 PM

52W Low on Oct 23, 2026

Volume: 1,066

Abbott India Ltd.

27 Nov 2025

26685.00

1.29%

Abbott India (BUY): Visibility of margin improvement

Buy: Abbott India Ltd.

BOB Capital Markets Ltd.

Mixtard 50 injectables off the shelf from Aug'25, yet monthly sales were Rs705 mn inAug'25, 762 mn in Sep'25 and Rs 710 mn in Oct'25

Abbott India Ltd. is trading above all available SMAs